REDWOOD
CITY, Calif., Jan. 4, 2024
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical
device company that is delivering comprehensive, life-changing
solutions for the treatment of chronic pain, today announced that
members of its management team will participate in the 42nd Annual
J.P. Morgan Healthcare Conference on Thursday, January 11, 2024. The company's formal
presentation will begin at 8:15 am
PST (11:15 am EST).
A live webcast of the presentation as well as replay of the
webcast will be available on the Events and Presentations page in
the Investors section of the company's website at
www.nevro.com.
About Nevro
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on delivering comprehensive, life-changing solutions that continue
to set the standard for enduring patient outcomes in chronic pain
treatment. The company started with a simple mission to help more
patients suffering from debilitating pain and developed its
proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic
innovation that has impacted the lives of more than 115,000
patients globally. Nevro's comprehensive HFX™ spinal cord
stimulation (SCS) platform includes a Senza™ SCS system and support
services for the treatment of chronic pain of the trunk and limb
and painful diabetic neuropathy. Nevro recently added a
minimally invasive treatment option for patients suffering from
chronic sacroiliac joint ("SI joint") pain and now provides the
most comprehensive portfolio of products in the SI
joint fusion space, designed to meet the preferences of
physicians and varying patient needs and improve outcomes and
quality of life for patients.
Senza®, Senza II®, Senza Omnia™, and HFX iQ™ are the only SCS
systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's
unique support services provide every patient with an HFX Coach™
throughout their pain relief journey and every physician with HFX
Cloud™ insights for enhanced patient and practice management.
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz
Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm,
HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo,
HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo,
RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are
trademarks or registered trademarks of Nevro Corp. Patents covering
Senza HFX iQ and other Nevro products are listed at
Nevro.com/patents.
To learn more about Nevro, connect with us
on LinkedIn, Twitter, Facebook, and Instagram.
Investors and Media:
Angie McCabe
Vice President, Investor Relations &
Corporate Communications
angeline.mccabe@nevro.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nevro-to-present-at-42nd-annual-jp-morgan-healthcare-conference-302026610.html
SOURCE Nevro Corp.